新闻中心

News Center

Home page

All Categories



Company News

Industry News

The company participated in the 14th National Psychiatry Academic Conference

Release Time

2022-06-22 10:27

From August 31st to September 3rd, 2016, the company participated in the 14th National Psychiatry Academic Conference held in Changsha, Hunan. In this conference, an unprecedented 3,000 experts participated, and the academic atmosphere was strong. During the period, the company displayed the brand of the company and Oranzhi by setting up a special exhibition. The company's Indian-style booth design and intelligent interactive area presentation attracted more than 1,000 experts to the booth for interactive exchanges. About 700 experts joined the Oran's WeChat public platform, expressing their willingness to pay attention to and help Oran's growth.

The 1202 group of the private board of directors of the experience workshop came to the company to learn and exchange

The company organized a seminar on "Interpretation of the external environment under the background of the new medical reform and business tax reform"

The 1202 group of the private board of directors of the experience workshop came to the company to learn and exchange

The company organized a seminar on "Interpretation of the external environment under the background of the new medical reform and business tax reform"

Related News

Foncoo Pharmaceutical participated in the 19th National Psychiatry Academic Conference of the Chinese Medical Association

Sponsored by the Chinese Medical Association and the Psychiatry Branch of the Chinese Medical Association, and organized by the Chongqing Medical Association, the Psychiatry Branch of the Chongqing Medical Association, the First Affiliated Hospital of Chongqing Medical University, and the University City Hospital Affiliated to Chongqing Medical University The conference and the Academic Conference on Child and Adolescent Psychiatry were successfully held at Chongqing Yuelai International Conference Center from December 21 to 24, 2021.

2022-05-25

2021-Foncoo Public Welfare

On October 15, 2021, Foncoo Pharmaceutical donated 100,000 yuan in cash to the "Gu Xueqiu Pharmacy Education Fund" public welfare student aid project of the Beijing Renren Public Welfare Foundation-Shenyang Pharmaceutical University.

2022-05-25

Foncoo Pharmaceutical's corporate culture 5.0 was officially released

Official announcement! Seriously, don't be distracted!

2022-05-25

Foncoo Pharmaceutical participated in the 16th National Academic Conference on Psychiatric Hospital Management

On October 29-31, 2021, the 16th National Academic Conference on Psychiatric Hospital Management, hosted by the Chinese Hospital Association and the Chinese Hospital Association Psychiatric Hospital Branch, was held in Chongqing.

2022-05-25

"Bupropion Hydrochloride Sustained-Release Tablets (II)" exclusively sold by Foncoo Pharmaceuticals was approved in China

Recently, "Bupropion Hydrochloride Sustained-Release Tablets (II) (150mg, 300mg)", exclusively sold by Pangu Pharmaceuticals (Mainland China), was approved by the State Drug Administration and deemed to have passed the consistency evaluation. The product, developed by Shanghai Xuantai Pharmaceuticals, was previously approved by the FDA in August 2017 and was marketed in the United States.

2022-05-25

Foncoo Pharmaceutical participated in the 9th China Schizophrenia Forum

From October 22 to 24, 2021, the "Ninth China Schizophrenia Forum" was grandly held in Wuhan. The theme of this forum is "Infection, Inflammation and Schizophrenia".

2022-05-25

0755-82873500

Room 1502-1506, Building D2, Nanshan iPark, No.1001 Xue Yuan Boulevard, Nanshan District, Shenzhen, China.

0755-82873510

京ICP备10002622号-38

0755-82873500

0755-82873510